First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.

Autor: Narayan, Rupa1 (AUTHOR) rnarayan3@mgh.harvard.edu, Piérola, Ana Alfonso2 (AUTHOR), Donnellan, William B.3 (AUTHOR), Yordi, Antonieta Molero4 (AUTHOR), Abdul‐Hay, Maher5 (AUTHOR), Platzbecker, Uwe6 (AUTHOR), Subklewe, Marion7 (AUTHOR), Kadia, Tapan Mahendra8 (AUTHOR), Alonso‐Domínguez, Juan Manuel9 (AUTHOR), McCloskey, James10 (AUTHOR), Bradford, Kathryn11 (AUTHOR), Curtis, Martin12 (AUTHOR), Daskalakis, Nikki11 (AUTHOR), Guttke, Christina11 (AUTHOR), Safer, Karim11 (AUTHOR), Hiebert, Brett13 (AUTHOR), Murphy, Joseph14 (AUTHOR), Li, Xiang11 (AUTHOR), Duchin, Ken11 (AUTHOR), Esteban, Daniel15 (AUTHOR)
Zdroj: CTS: Clinical & Translational Science. Mar2024, Vol. 17 Issue 3, p1-18. 18p.
Databáze: Academic Search Ultimate